RSV Burden of Disease in Adults - a new threat

1. WHO - Respiratory Syncytial Virus (RSV) disease Available at: https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/vaccine-standardization/respiratory-syncytial-virus-disease, Accessed 13.07.2023. WHO - Respiratory Syncytial Virus (RSV) disease Available at: https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/vaccine-standardization/respiratory-syncytial-virus-disease , accessed 13.07.2023 . Search in Google Scholar

2. Nam H and Ison M, Respiratory syncytial virus infection in adults, BMJ 2019 Sep 10;366:l5021. Nam H Ison M Respiratory syncytial virus infection in adults , BMJ 2019 Sep 10 ; 366 : l5021 . Search in Google Scholar

3. Shang et al., Respiratory syncytial virus: from pathogenesis to potential therapeutic strategies, Int J Biol Sci 2021 Sep 27;17(14):4073–4091. Shang , Respiratory syncytial virus: from pathogenesis to potential therapeutic strategies , Int J Biol Sci 2021 Sep 27 ; 17 ( 14 ): 4073 – 4091 . Search in Google Scholar

4. Sun Y and López C, The innate immune response to RSV: Advances in our understanding of critical viral and host factors, Vaccine 2017 Jan 11;35(3):481–488. Sun Y López C The innate immune response to RSV: Advances in our understanding of critical viral and host factors , Vaccine 2017 Jan 11 ; 35 ( 3 ): 481 – 488 . Search in Google Scholar

5. Talbot et al., Respiratory Syncytial Virus in Older Adults. A Hidden Annual Epidemic, Infectious Diseases in Clinical Practice, Nov 2016. Talbot , Respiratory Syncytial Virus in Older Adults . A Hidden Annual Epidemic, Infectious Diseases in Clinical Practice , Nov 2016 . Search in Google Scholar

6. Cantú-Flores K, Rivera-Alfaro G, Muñoz-Escalante JC, Noyola DE. Global distribution of respiratory syncytial virus A and B infections: a systematic review. Pathog Glob Health. 2022 Oct; 116(7):398–409. doi: 10.1080/20477724.2022.2038053. Epub 2022 Feb 14. PMID: 35156555; PMCID: PMC9518599. Cantú-Flores K Rivera-Alfaro G Muñoz-Escalante JC Noyola DE. Global distribution of respiratory syncytial virus A and B infections: a systematic review . Pathog Glob Health . 2022 Oct ; 116 ( 7 ): 398 – 409 . doi: 10.1080/20477724.2022.2038053 . Epub 2022 Feb 14. PMID: 35156555 ; PMCID: PMC9518599 . Open DOISearch in Google Scholar

7. Intensified circulation of respiratory syncytial virus (RSV) and associated hospital burden in the EU/EEA, Available at https://www.ecdc.europa.eu/sites/default/files/documents/RRA-20221128-473.pdf Accessed 12.07.2023. Intensified circulation of respiratory syncytial virus (RSV) and associated hospital burden in the EU/EEA , Available at https://www.ecdc.europa.eu/sites/default/files/documents/RRA-20221128-473.pdf accessed 12.07.2023 . Search in Google Scholar

8. National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases Available at https://www.cdc.gov/rsv/about/transmission.html Accessed 12.07.2023. National Center for Immunization and Respiratory Diseases (NCIRD) , Division of Viral Diseases Available at https://www.cdc.gov/rsv/about/transmission.html accessed 12.07.2023 . Search in Google Scholar

9. Centers for Disease Control and Prevention. Respiratory Syncytial Virus Infection (RSV). Available at: https://www.cdc.gov/rsv/index.html#:~:text=Respiratory%20syncytial%20(sin%2DSISH%2D,for%20infants%20and%20older%20adults. Accessed 14.07.2023. Centers for Disease Control and Prevention . Respiratory Syncytial Virus Infection (RSV) . Available at: https://www.cdc.gov/rsv/index.html#:~:text=Respiratory%20syncytial%20(sin%2DSISH%2D,for%20infants%20and%20older%20adults . accessed 14.07.2023 . Search in Google Scholar

10. National Collaborating Centre for Infectious Diseases. Respiratory Syncytial Virus (RSV) 2022 Update. Available at: https://nccid.ca/debrief/respiratory-syncytial-virus-rsv/. Accesses 14.07.2023. National Collaborating Centre for Infectious Diseases . Respiratory Syncytial Virus (RSV) 2022 Update . Available at: https://nccid.ca/debrief/respiratory-syncytial-virus-rsv/ . Accesses 14.07.2023 . Search in Google Scholar

11. Government of Canada. Pathogen Safety Data Sheets: Infectious Substances – Respiratory syncytial virus. Available at: https://www.canada.ca/en/public-health/services/laboratory-biosafety-biosecurity/pathogen-safety-data-sheets-risk-assessment/respiratory-syncytial-virus.html Acccesed 14.07.2023. Government of Canada . Pathogen Safety Data Sheets: Infectious Substances – Respiratory syncytial virus . Available at: https://www.canada.ca/en/public-health/services/laboratory-biosafety-biosecurity/pathogen-safety-data-sheets-risk-assessment/respiratory-syncytial-virus.html Acccesed 14.07.2023 . Search in Google Scholar

12. Belongia et al., Clinical Features, Severity, and Incidence of RSV Illness During 12 Consecutive Seasons in a Community Cohort of Adults ≥60 Years Old, Open Forum Infect Dis 2018 Nov 27;5(12). Belongia , Clinical Features, Severity, and Incidence of RSV Illness During 12 Consecutive Seasons in a Community Cohort of Adults ≥60 Years Old , Open Forum Infect Dis 2018 Nov 27 ; 5 ( 12 ). Search in Google Scholar

13. Jeannoël et al., Microorganisms associated with respiratory syncytial virus pneumonia in the adult population, Eur J Clin Microbiol Infect Dis 2019 Jan;38(1):157–160; Jeannoël , Microorganisms associated with respiratory syncytial virus pneumonia in the adult population , Eur J Clin Microbiol Infect Dis 2019 Jan ; 38 ( 1 ): 157 – 160 ; Search in Google Scholar

14. Hamilton MA, Liu Y, Calzavara A, et al. Predictors of all-cause mortality among patients hospitalized with influenza, respiratory syncytial virus, or SARS-CoV-2. Influenza Other Respir Viruses. Nov 2022;16(6):1072–1081. doi:10.1111/irv.13C04. Hamilton MA Liu Y Calzavara A Predictors of all-cause mortality among patients hospitalized with influenza, respiratory syncytial virus, or SARS-CoV-2 . Influenza Other Respir Viruses. Nov 2022 ; 16 ( 6 ): 1072 – 1081 . doi: 10.1111/irv.13C04 . Open DOISearch in Google Scholar

15. RSV in Adults | American Lung Association Available at: RSV in Adults | American Lung Association Accessed 14.07.2023. RSV in Adults | American Lung Association Available at: RSV in Adults | American Lung Association Accessed 14.07.2023 . Search in Google Scholar

16. Falsey et al., Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness J Infect Dis 2014 Jun 15;209(12):1873–8; Falsey , Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness J Infect Dis 2014 Jun 15 ; 209 ( 12 ): 1873 – 8 ; Search in Google Scholar

17. Shang et al., Respiratory syncytial virus: from pathogenesis to potential therapeutic strategies, Int J Biol Sci 2021 Sep 27;17(14):4073–4091. Shang , Respiratory syncytial virus: from pathogenesis to potential therapeutic strategies , Int J Biol Sci 2021 Sep 27 ; 17 ( 14 ): 4073 – 4091 . Search in Google Scholar

18. Stephens LM, et al., Considerations for a Respiratory Syncytial Virus Vaccine Targeting an Elderly Population, Vaccines (Basel). 2021;9(6):624. Stephens LM , Considerations for a Respiratory Syncytial Virus Vaccine Targeting an Elderly Population , Vaccines (Basel) . 2021 ; 9 ( 6 ): 624 . Search in Google Scholar

19. Crooke SN, et al., Immunosenescence and human vaccine immune responses, Immun Ageing 2019 Sep 13;16:25. Crooke SN , Immunosenescence and human vaccine immune responses , Immun Ageing 2019 Sep 13 ; 16 : 25 . Search in Google Scholar

20. RSV Surveillance and Research | CDC Available at: RSV Surveillance and Research | CDC, Accessed 14.07.2023. RSV Surveillance and Research | CDC Available at: RSV Surveillance and Research | CDC , Accessed 14.07.2023 . Search in Google Scholar

21. RSV virus expected to add pressure on hospitals in many EU/EEA countries this season (europa.eu) Available at: RSV virus expected to add pressure on hospitals in many EU/EEA countries this season (europa.eu), Accesses 14.07.2023. RSV virus expected to add pressure on hospitals in many EU/EEA countries this season (europa.eu) Available at: RSV virus expected to add pressure on hospitals in many EU/EEA countries this season (europa.eu) , Accesses 14.07.2023 . Search in Google Scholar

22. Shi T, Denouel A, Tietjen AK, et al. Global Disease Burden Estimates of Respiratory Syncytial Virus-Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis. Journal of Infectious Diseases. 2020;222(Suppl 7):S577–S583. Shi T Denouel A Tietjen AK Global Disease Burden Estimates of Respiratory Syncytial Virus-Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis . Journal of Infectious Diseases . 2020 ; 222 ( Suppl 7 ): S577 – S583 . Search in Google Scholar

23. Shi T, Vennard S, Jasiewicz F, Brogden R, Nair H, Investigators R. Disease Burden Estimates of Respiratory Syncytial Virus related Acute Respiratory Infections in Adults With Comorbidity: A Systematic Review and Meta-Analysis. J Infect Dis. Aug 12 2022;226(Supplement_1):S17–S21. doi:10.1093/infdis/jiab040. Shi T Vennard S Jasiewicz F Brogden R Nair H Investigators R. Disease Burden Estimates of Respiratory Syncytial Virus related Acute Respiratory Infections in Adults With Comorbidity: A Systematic Review and Meta-Analysis . J Infect Dis . Aug 12 2022 ; 226 ( Supplement_1 ): S17 – S21 . doi: 10.1093/infdis/jiab040 . Open DOISearch in Google Scholar

24. Falsey AR, Walsh EE. Respiratory syncytial virus infection in elderly adults. Drugs Aging. 2005;22(7):577–87. doi:10.2165/00002512-200522070-00004. Falsey AR Walsh EE. Respiratory syncytial virus infection in elderly adults . Drugs Aging . 2005 ; 22 ( 7 ): 577 – 87 . doi: 10.2165/00002512-200522070-00004 . Open DOISearch in Google Scholar

25. People at High Risk for Severe RSV Infection | CDC Available at: People at High Risk for Severe RSV Infection | CDC, Accessed 14.07.2023. People at High Risk for Severe RSV Infection | CDC Available at: People at High Risk for Severe RSV Infection | CDC , Accessed 14.07.2023 . Search in Google Scholar

26. Intensified circulation of respiratory syncytial virus (RSV) and associated hospital burden in the EU/EEA Available at: https://www.ecdc.europa.eu/sites/default/files/documents/RRA-20221128-473.pdf, Accessed 14.07.2023. Intensified circulation of respiratory syncytial virus (RSV) and associated hospital burden in the EU/EEA Available at: https://www.ecdc.europa.eu/sites/default/files/documents/RRA-20221128-473.pdf , accessed 14.07.2023 . Search in Google Scholar

27. Branche A, Why Making a Diagnosis of Respiratory Syncytial Virus Should Matter to Clinicians, Clin Infect Dis 2019 Jul 2;69(2):204–206. Branche A Why Making a Diagnosis of Respiratory Syncytial Virus Should Matter to Clinicians , Clin Infect Dis 2019 Jul 2 ; 69 ( 2 ): 204 – 206 . Search in Google Scholar

28. Tin Tin Htar et al., The burden of respiratory syncytial virus in adults: a systematic review and meta-analysis, Epidemiol Infect 2020; 148: e48. Htar Tin Tin , The burden of respiratory syncytial virus in adults: a systematic review and meta-analysis , Epidemiol Infect 2020 ; 148 : e48 . Search in Google Scholar

29. Tseng HF et al., Severe Morbidity and Short- and Mid- to Long-term Mortality in Older Adults Hospitalized with Respiratory Syncytial Virus Infection, J Infect Dis 2020 Sep 14;222(8):1298–1310. Tseng HF , Severe Morbidity and Short- and Mid- to Long-term Mortality in Older Adults Hospitalized with Respiratory Syncytial Virus Infection , J Infect Dis 2020 Sep 14 ; 222 ( 8 ): 1298 – 1310 . Search in Google Scholar

30. Zhou Y et al., Severity and mortality of respiratory syncytial virus vs influenza A infection in hospitalized adults in China, Influenza Other Respir Viruses 2020 Sep;14(5):483–490. Zhou Y , Severity and mortality of respiratory syncytial virus vs influenza A infection in hospitalized adults in China , Influenza Other Respir Viruses 2020 Sep ; 14 ( 5 ): 483 – 490 . Search in Google Scholar

31. Bosco E et al., Estimated Cardiorespiratory Hospitalizations Attributable to Influenza and Respiratory Syncytial Virus Among Long-term Care Facility Residents, JAMA Netw Open. 2021 Jun; 4(6). Bosco E , Estimated Cardiorespiratory Hospitalizations Attributable to Influenza and Respiratory Syncytial Virus Among Long-term Care Facility Residents , JAMA Netw Open . 2021 Jun ; 4 ( 6 ). Search in Google Scholar

32. Riester MR et al., Relationships Between Community Virus Activity and Cardiorespiratory Rehospitalizations From Post-Acute Care, J Am Med Dir Assoc. 2022 Aug; 23(8): 1418–1423. e7. Riester MR , Relationships Between Community Virus Activity and Cardiorespiratory Rehospitalizations From Post-Acute Care , J Am Med Dir Assoc . 2022 Aug ; 23 ( 8 ): 1418 – 1423 . e7 . Search in Google Scholar

33. Goldman CR et al., Severe Clinical Outcomes Among Adults Hospitalized With Respiratory Syncytial Virus Infections, New York City, 2017-2019, Public Health Rep 2022 Sep-Oct;137(5):929–935. Goldman CR , Severe Clinical Outcomes Among Adults Hospitalized With Respiratory Syncytial Virus Infections, New York City, 2017-2019 , Public Health Rep 2022 Sep-Oct ; 137 ( 5 ): 929 – 935 . Search in Google Scholar

34. CDC-Respiratory Syncytial Virus Infection (RSV), Available at: https://www.cdc.gov/rsv/about/symptoms.html, Accessed 13.07.2023. CDC-Respiratory Syncytial Virus Infection (RSV) , Available at: https://www.cdc.gov/rsv/about/symptoms.html , accessed 13.07.2023 . Search in Google Scholar

35. Public Health England. Public Health England. Respiratory syncytial virus (RSV): symptoms, transmission, prevention, treatment. 16 September 2021. https://www.gov.uk/government/publications/respiratory-syncytial-virus-rsv-symptoms-transmission-prevention-treatment/respiratory-syncytial-virus-rsv-symptoms-transmission-prevention-treatment. Accessed 13 July 2023. Public Health England. Public Health England . Respiratory syncytial virus (RSV): symptoms, transmission, prevention, treatment . 16 September 2021 . https://www.gov.uk/government/publications/respiratory-syncytial-virus-rsv-symptoms-transmission-prevention-treatment/respiratory-syncytial-virus-rsv-symptoms-transmission-prevention-treatment . accessed 13 July 2023 . Search in Google Scholar

36. FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine Available at: https://www.fda.gov/news-events/press-announcements/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine, Accessed 13.07.2023. FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine Available at: https://www.fda.gov/news-events/press-announcements/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine , accessed 13.07.2023 . Search in Google Scholar

37. U.S. FDA Approves ABRYSVO™, Pfizer’s Vaccine for the Prevention of Respiratory Syncytial Virus (RSV) in Older Adults Available at: https://www.pfizer.com/news/press-release/press-release-detail/us-fda-approves-abrysvotm-pfizers-vaccine-prevention, Accessed 13.07.2023. U.S. FDA Approves ABRYSVO™, Pfizer’s Vaccine for the Prevention of Respiratory Syncytial Virus (RSV) in Older Adults Available at: https://www.pfizer.com/news/press-release/press-release-detail/us-fda-approves-abrysvotm-pfizers-vaccine-prevention , accessed 13.07.2023 . Search in Google Scholar

38. Walsh EE et al. Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults, N Engl J Med2023;388:1465–1477. Walsh EE Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults , N Engl J Med 2023 ; 388 : 1465 – 1477 . Search in Google Scholar

39. Vaccines and Related Biological Products Advisory Committee February 28 - March 1, 2023 Meeting Presentation-Bivalent RSV Prefusion F Vaccine in Adults Over 60 Years of Age Available at https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-february-28-march-1-2023-meeting#event-materials, Accessed 14.07.2023. Vaccines and Related Biological Products Advisory Committee February 28 - March 1, 2023 Meeting Presentation-Bivalent RSV Prefusion F Vaccine in Adults Over 60 Years of Age Available at https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-february-28-march-1-2023-meeting#event-materials , accessed 14.07.2023 . Search in Google Scholar

40. Arexvy SmPC, Available at: arexvy-epar-product-information_en.pdf (europa.eu), Accessed 14.07.2023. Arexvy SmPC , Available at: arexvy-epar-product-information_en.pdf (europa.eu) , Accessed 14.07.2023 . Search in Google Scholar

41. RSV Vaccine and mAb Snapshot Available at https://www.path.org/resources/rsv-vaccine-and-mab-snapshot/Accessed 14.07.2023. RSV Vaccine and mAb Snapshot Available at https://www.path.org/resources/rsv-vaccine-and-mab-snapshot/ accessed 14.07.2023 . Search in Google Scholar

42. Government of Canada. Canada communicable disease report: respiratory syncytial virus (RSV). April 2020. https://www.canada.ca/en/public-health/services/reports-publications/cana-da-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020.html. Accessed 14.07. 2023. Government of Canada . Canada communicable disease report: respiratory syncytial virus (RSV) . April 2020 . https://www.canada.ca/en/public-health/services/reports-publications/cana-da-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020.html . accessed 14.07.2023 . Search in Google Scholar

43. Government of South Australia. Respiratory syncytial virus (RSV) infection—including symptoms, treatment and prevention. 2021. https://www.sahealth.sa.gov.au/wps/wcm/connect/public+content/sa+health+internet/conditions/infectious+diseases/respiratory+syncytial+virus+rsv+infection/respiratory+syncytial+virus+rsv+infection+-+including+symptoms+treatment+and+prevention. Accessed 14.07. 2023. Government of South Australia . Respiratory syncytial virus (RSV) infection—including symptoms, treatment and prevention . 2021 . https://www.sahealth.sa.gov.au/wps/wcm/connect/public+content/sa+health+internet/conditions/infectious+diseases/respiratory+syncytial+virus+rsv+infection/respiratory+syncytial+virus+rsv+infection+-+including+symptoms+treatment+and+prevention . accessed 14.07. 2023 . Search in Google Scholar

44. UK Health Security Agency. UK Health Security Agency. Respiratory syncytial virus (RSV): the Green Book, Chapter 27a v2_0. 4 September 2015. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/458469/Green_Book_Chapter_27a_v2_0W.PDF. Accessed 14.07. 2023. UK Health Security Agency. UK Health Security Agency . Respiratory syncytial virus (RSV): the Green Book, Chapter 27a v2_0 . 4 September 2015 . https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/458469/Green_Book_Chapter_27a_v2_0W.PDF . accessed 14.07. 2023 . Search in Google Scholar

45. CDC. US Centers for Disease Control and Prevention. Respiratory syncytial virus: prevention. 2021. https://www.cdc.gov/rsv/about/prevention.html. Accessed 14.07. 2023. CDC . US Centers for Disease Control and Prevention. Respiratory syncytial virus: prevention . 2021 . https://www.cdc.gov/rsv/about/prevention.html . accessed 14.07. 2023 . Search in Google Scholar

46. Respiratory syncytial virus (RSV) immunisation programme: JCVI advice, 7 June 2023, Available at: https://www.gov.uk/government/publications/rsv-immunisation-programme-jcvi-advice-7-june-2023/respiratory-syncytial-virus-rsv-immunisation-programme-jcvi-advice-7-june-2023, Accessed 14.07.2023 Respiratory syncytial virus (RSV) immunisation programme: JCVI advice , 7 June 2023 , Available at: https://www.gov.uk/government/publications/rsv-immunisation-programme-jcvi-advice-7-june-2023/respiratory-syncytial-virus-rsv-immunisation-programme-jcvi-advice-7-june-2023 , accessed 14.07.2023 Search in Google Scholar